G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

Podcast

Hear 
G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences.
Hear the podcast 
Sign up to receive email notifications about our upcoming events and news.


 
Burrill is the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publishes a wide range of bio-intelligence reports including: its annual State of the Industry, The Personalized Medicine Report, The Stem Cell Report, and periodic newsletters covering Canada, China, Europe, India, Japan and Partnering/M&A. Burrill also publishesThe Journal of Life Sciences a bimonthly magazine available at www.tjols.com/currentissue.

The Personalized Medicine Intelligence Report 2007



The Burrill Personalized Medicine Report, published annually, is designed to keep reader abreast of the latest global developments in this rapidly evolving area. The Report is designed to provide a “snapshot” on a rapidly growing sector and will serve as a reference to the major players and technologies.

Editorial Focus: In the foreseeable future a trip to the doctor’s office will be a radically different experience to what it is today. Armed with our complete genetic profile information about predisposition to disease, the appropriate remedial therapies, even what foods to eat will be part of the doctor’s advice. Welcome to the emerging world of personalized medicine an all-embracing term that covers:

  • Predictive Medicine—one of the newest and most exciting developments in medicine today representing a paradigm shift from medicine as the treatment of disease, to medicine as the true prevention of illness.
  • Pharmacogenomics—tailoring the right medicine to the right individual at the right time.
  • Molecular diagnostics—Scientific advances in genomics and proteomics have led to a new generation of healthcare tools that will enable more effective prediction, diagnosis, characterization, monitoring, and treatment of diseases.
  • Biomarkers—Potential biomarker applications extend from drug discovery and development to diagnostic tools.

The 2008 Personalized Medicine report will be available in November.


Add to cart$95.00